Media Report_INNOVATIVE DISCOVERIES ARE COMING SOON

C&EN

Molecular glues are beginning to stick

Degron Therapeutics is featured in the article about molecular-glue drug discovery.

BIOCENTURY

June 9 Quick Takes: Venture rounds for Tessa, Degron, Ancora, Charm and Relation

Cross-border molecular glue newcoDegron raises $22M series A

BioWorld

Degron raises $22M to develop molecular glue-based protein degradation platform

Degron Therapeutics Inc. has raised $22 million in a series A round to develop its drug development

C&EN

Molecular glue firms get investment, strike partnerships

Degron is the latest to attract funding for new method of degrading proteins

Scrip

Can China Innovate? Degron Aims For First-In-Class TPD Therapies

New Funds For Novel Platform